Sewoong Oh, Executive Director/CSO, R&D

Professional Overview

Sewoong Oh is an accomplished pharmaceutical executive with extensive expertise in R&D strategy, planning, and leadership. As the Executive Director/Chief Scientific Officer (CSO) of R&D at Yuhan Corporation, he oversees the company's research and development efforts, driving innovation and advancing the organization's scientific capabilities.

Experience Summary

Current Role

In his current role as Executive Director/CSO of R&D at Yuhan Corporation, Sewoong is responsible for spearheading the company's research and development strategy. He leads a team of scientists and researchers, guiding the development of new drug candidates and innovative pharmaceutical solutions. Under his leadership, Yuhan Corporation has significantly enhanced its R&D pipeline and strengthened its position as a leading pharmaceutical company in South Korea.

Career Progression

Prior to his current role, Sewoong served as the Executive Director/Deputy CSO of R&D at Yuhan Corporation, where he played a pivotal role in shaping the company's research and development initiatives. He previously held the position of Director, Head of R&D Strategy & Planning, where he was instrumental in aligning the organization's research priorities with its overall business objectives. Sewoong's extensive experience also includes a long tenure as a Principal Scientist at JW Pharma (previously ChoongWae Pharma), where he contributed to the development of innovative pharmaceutical products.

Academic Background

Sewoong Oh holds a strong academic background, having obtained his degree in a relevant field. His specialized knowledge and research expertise have been instrumental in driving Yuhan Corporation's scientific advancements.

Areas of Expertise

Sewoong's areas of expertise include strategic R&D planning, pipeline management, scientific leadership, and cross-functional collaboration. He has a deep understanding of the pharmaceutical industry and a proven track record of delivering impactful research and development initiatives.

Professional Impact

Under Sewoong's guidance, Yuhan Corporation has successfully expanded its R&D portfolio and accelerated the development of promising drug candidates. His ability to align research priorities with the company's business goals has been instrumental in driving the organization's growth and positioning it as a prominent player in the South Korean pharmaceutical landscape.

Conclusion

Sewoong Oh's extensive experience, scientific expertise, and strategic leadership have made him a valuable asset to Yuhan Corporation. As the Executive Director/CSO of R&D, he continues to drive innovation, enhance the company's research capabilities, and contribute to the development of transformative pharmaceutical solutions that improve patient outcomes.